Silexion Therapeutics Corp (SLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 11-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -196 | N/A | N/A | N/A |
| Other Working Capital | 121 | 121 | N/A | N/A |
| Operating Cash Flow | $-75 | $121 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 150 | N/A | N/A | N/A |
| Common Stock Issued | 25 | N/A | N/A | N/A |
| Other Financing Activity | -48 | 175 | 0 | 0 |
| Financing Cash Flow | $127 | $175 | $N/A | $N/A |
| End Cash Position | 52 | N/A | N/A | N/A |
| Net Cash Flow | $52 | $296 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -75 | 121 | N/A | N/A |
| Free Cash Flow | -75 | 121 | 0 | 0 |